FFR and iFR: Where Do We Stand Today?
Coronary Physiology: New Insights
Who Will Treat the Most Complex Patients? No Success Goes Unpunished.
Live Case & Lecture 6: Complex PCI
Provisional Stenting in Left Main vs. Non-Left Main Complex Bifurcation Stenoses: Is There a Difference?
New Concept of Bifurcation PCI
Don't Forget About Dual Pathway Inhibition: When DOAC Should NOT Be Standard Treatment
All About New Data of Antithrombotics
Bicuspid TAVR: All the Technical Issues and Data from Asan Medical Center
TAVR: Future Perspectives
The Series of FAME Studies: A Paradigm Shift in Our Thinking About Interventional Cardiology
Coronary Imaging & Physiology: Updated Concepts and Issues
Calcified Nodules in Complex PCI: Are They All the Same and How Should We Treat?
All About Tips & Tricks for Complex PCI
New Launched M-TEER Device for Degenerative Mitral Regurgitation: PASCAL Experiences in Japan
Evolution of Mitral and Tricuspid Interventions
Following BEST-CLI and BASIL-2: How to “Best” Serve Critical Limb Threatening Ischemia?
EVAR, TEVAR and Peripheral Interventions
AI Application of Cardiovascular Imaging
MedTech Innovation
Severe AS with Low Valve Calcium Score: Different Prognosis?
All About New Data from Asan Medical Center
Impact of Intravascular Imaging-guided PCI or CABG in Multi-Vessel Disease: The BEST Extended Follow-Up Study
All About New Data from Asan Medical Center
Rule of 5-6-7-8 for Bifurcation PCI: It Is Time to Change in 2024
New Concept of Bifurcation PCI
Timing of Complete Revascularization With Multi-Vessel PCI for AMI: Insights From the COMPLETE Trial and Future Perspectives
Left Main & Multi-Vessel PCI: Now and Future
Moderate AS in HFrEF: Time to Treat is Now & Future Expectation from RCT
TAVR: Techniques and Issues
How Can We Further Improve Reperfusion in AMI?: Revising or Novel Approach
ACS and Acute MI: Brand New Issues
Revascularization for Left Main Disease: Updated Data, Global Guideline and Beyond
Left Main and Multi-Vessel Diseases: Updated Concept and Treatment
Choosing Wisely: FFR vs. Anatomy-guided Left Main PCI -The Rationale of the FATE-MAIN Trial
Left Main and Multi-Vessel Diseases: Updated Concept and Treatment
Implications of the ISCHEMIA Trial on Patient Selection for CTO-PCI
CTO-PCI: To Treat, or Not To Treat
ASSURE-DES Trial: Optimal Antiplatelet Strategy in DES Patients During Noncardiac Surgery
Ongoing Trials from Asan Medical Center
OCTIVUS Trial: OCT- vs. IVUS-guided PCI in All-comer PCI
Late-Breaking Clinical Trials 2024
PREVENT trial: Confirmative RCT of Preventive PCI for Vulnerable Plaques
Vulnerable Plaque Treatment 2024
Long-term DOAC Management of AF and Stable CAD: Expectation on the EPIC-CAD Trial After the AFIRE Trial
All About New Data of Antithrombotics
50 Years Long Journey of Coronary Physiology: From Humble To Great
TCTAP "Master of the Masters" Award 2024
DCB Use in Your PCI Practice: Adjunctive Therapy or Standard of Care?
Evolving PCI Devices: Coronary DES, BRS, and DCB
What Are Novel and Future Antithrombotic Drugs in ACS and PCI? Are There Still Unmet Needs?
Antithrombotic Hot Issues in ACS/PCI: What Are New in 2024?
TAVR-in-TAVR: The NEXT Challenging Issue in Lifetime TAVR Management
TAVR: Key Issues in 2024